Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
22.5%
% of WDNA's 91 holdings also in IDNA
42.6%
% of IDNA's 51 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
IOVANCE BIOTHERAPEUTICS INC | 3.9% | 3.0% | 3.0% |
|
TWIST BIOSCIENCE CORP. | 3.4% | 2.1% | 2.1% |
|
BEAM THERAPEUTICS, INC. | 1.4% | 2.2% | 1.4% |
|
GERON CORP | 1.4% | 2.3% | 1.4% |
|
BLUEPRINT MEDICINES CORP. | 2.2% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to IDNA
|
FATE THERAPEUTICS INC | 3.1% |
 |
NOVOZYMES A/S-B SHARES | 2.4% |
|
BRIDGEBIO PHARMA, INC. | 2.0% |
|
NATERA INC | 1.9% |
|
ELI LILLY & CO | 1.9% |
|
VERICEL CORPORATION | 1.7% |
|
AGIOS PHARMACEUTICALS INC | 1.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.6% |
|
AMICUS THERAPEUTICS INC | 1.4% |
|
VERTEX PHARMACEUTICALS INC | 1.3% |
WDNA Underweight Relative to IDNA
|
REVOLUTION MEDICINES, INC. | -5.6% |
|
MODERNA, INC. | -4.3% |
|
SAREPTA THERAPEUTICS INC | -4.2% |
|
EXELIXIS INC | -4.0% |
 |
SANOFI-AVENTIS | -3.9% |
|
INCYTE CORP | -3.8% |
|
MERCK & CO. INC. | -3.6% |
|
GENMAB A/S | -3.6% |
 |
ROCHE HOLDING LTD | -3.5% |
|
REGENERON PHARMACEUTICALS | -3.1% |